Genetic Predictors of Benefit to Pembrolizumab
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Denosumab as an add-on Neoadjuvant Treatment (GeparX)
- Status
- COMPLETED
- Phase
- PHASE2
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
- Status
- RECRUITING
- Phase
- PHASE3
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
- Status
- UNKNOWN
- Phase
- PHASE2
Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCHN )
- Status
- TERMINATED
- Phase
- PHASE2
Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1
- Status
- COMPLETED
- Phase
- PHASE3